Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use-result survey of FluMist intranasal spray
jRCT2031240117Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of live attenuated influenza vaccine in influenza, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Safety specifications and factors affecting safety. Started Sep 2024; status: active, not recruiting.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2031240117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240117.